Spyridon was Chief Medical Officer at Vigil, and Chief Development Officer and Senior Vice President, Head of Development at Acadia Pharmaceuticals. Spyridon Papapetropoulos joined Bionomics in 2022.
Spyridon Papapetropoulos is currently President and Chief Executive Officer at Bionomics - View - Bionomics org chart
Create your alert
to follow the career of Spyridon Papapetropoulos.
Spyridon Papapetropoulos has a PhD from University of Patras.
Do you need to know more about Spyridon Papapetropoulos? More results.
Report an error
Update the org chart details of Spyridon Papapetropoulos.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.